Position in LXRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$117,290
-$132,046 QoQ
Shares Held
48,871
-69.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 148 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SCOTIA CAPITAL INC. holds $19,756,450 across 14 Biotechnology names. LXRX ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
1,343,726 | $8,882,028 | |
| 2 | BNTX |
BioNTech SE
|
45,000 | $4,187,250 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,981 | $3,467,672 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
34,722 | $1,633,322 | |
| 5 | EYPT |
EyePoint, Inc.
|
41,751 | $597,039 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
6,031 | $235,269 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
25,082 | $196,893 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
13,337 | $130,969 |
All Filings in LXRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $117,290 | 48,871 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $249,336 | 159,831 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||